Victor Peralta1,2, Manuel J Cuesta2,3. 1. Mental Health Department, Servicio Navarro de Salud, Pamplona, Spain. 2. Instituto de Investigación Sanitaria de Navarra (IdiSNA), Pamplona, Spain. 3. Psychiatry Service, Complejo Hospitalario de Navarra, Pamplona, Spain.
Abstract
Background: Motor abnormalities (MAs) of severe mental disorders have been traditionally neglected both in clinical practice and research, although they are an increasing focus of attention because of their clinical and neurobiological relevance. For historical reasons, most of the literature on MAs has been focused to a great extent on schizophrenia, and as a consequence their prevalence and featural properties in other psychiatric or neuropsychiatric disorders are poorly known. In this article, we evaluated the extent to which catatonic, extrapyramidal and neurological soft signs, and their associated clinical features, are present transdiagnostically. Methods: We examined motor-related features in neurodevelopmental (schizophrenia, obsessive compulsive disorder, autism spectrum disorders), "functional" (nonschizophrenic nonaffective psychoses, mood disorders) and neurodegenerative (Alzheimer's disease) disorders. Examination of the literature revealed that there have been very few comparisons of motor-related features across diagnoses and we had to rely mainly in disorder-specific studies to compare it transdiagnostically. Results: One or more motor domains had a substantial prevalence in all the diagnoses examined. In "functional" disorders, MAs, and particularly catatonic signs, appear to be markers of episode severity; in chronic disorders, although with different degree of strength or evidence, all motor domains are indicators of both disorder severity and poor outcome; lastly, in Alzheimer's disease they are also indicators of disorder progression. Conclusions: MAs appear to represent a true transdiagnostic domain putatively sharing neurobiological mechanisms of neurodevelopmental, functional or neurodegenerative origin.
Background: Motor abnormalities (MAs) of severe mental disorders have been traditionally neglected both in clinical practice and research, although they are an increasing focus of attention because of their clinical and neurobiological relevance. For historical reasons, most of the literature on MAs has been focused to a great extent on schizophrenia, and as a consequence their prevalence and featural properties in other psychiatric or neuropsychiatric disorders are poorly known. In this article, we evaluated the extent to which catatonic, extrapyramidal and neurological soft signs, and their associated clinical features, are present transdiagnostically. Methods: We examined motor-related features in neurodevelopmental (schizophrenia, obsessive compulsive disorder, autism spectrum disorders), "functional" (nonschizophrenic nonaffective psychoses, mood disorders) and neurodegenerative (Alzheimer's disease) disorders. Examination of the literature revealed that there have been very few comparisons of motor-related features across diagnoses and we had to rely mainly in disorder-specific studies to compare it transdiagnostically. Results: One or more motor domains had a substantial prevalence in all the diagnoses examined. In "functional" disorders, MAs, and particularly catatonic signs, appear to be markers of episode severity; in chronic disorders, although with different degree of strength or evidence, all motor domains are indicators of both disorder severity and poor outcome; lastly, in Alzheimer's disease they are also indicators of disorder progression. Conclusions: MAs appear to represent a true transdiagnostic domain putatively sharing neurobiological mechanisms of neurodevelopmental, functional or neurodegenerative origin.
Authors: Vijay A Mittal; Derek J Dean; Jessica A Bernard; Joseph M Orr; Andrea Pelletier-Baldelli; Emily E Carol; Tina Gupta; Jessica Turner; Daniel R Leopold; Briana L Robustelli; Zachary B Millman Journal: Schizophr Bull Date: 2013-12-27 Impact factor: 9.306
Authors: Paola Dazzan; Tuhina Lloyd; Kevin D Morgan; Jolanta Zanelli; Craig Morgan; Ken Orr; Gerard Hutchinson; Paul Fearon; Matthew Allin; Larry Rifkin; Philip K McGuire; Gillian A Doody; John Holloway; Julian Leff; Glynn Harrison; Peter B Jones; Robin M Murray Journal: Br J Psychiatry Date: 2008-09 Impact factor: 9.319
Authors: Xiaoming Du; Fow-Sen Choa; Joshua Chiappelli; Krista M Wisner; George Wittenberg; Bhim Adhikari; Heather Bruce; Laura M Rowland; Peter Kochunov; L Elliot Hong Journal: Biol Psychiatry Date: 2018-06-21 Impact factor: 13.382
Authors: Mario Maj; Jim van Os; Marc De Hert; Wolfgang Gaebel; Silvana Galderisi; Michael F Green; Sinan Guloksuz; Philip D Harvey; Peter B Jones; Dolores Malaspina; Patrick McGorry; Jouko Miettunen; Robin M Murray; Keith H Nuechterlein; Victor Peralta; Graham Thornicroft; Ruud van Winkel; Joseph Ventura Journal: World Psychiatry Date: 2021-02 Impact factor: 49.548
Authors: Dusan Hirjak; Stefan Fritze; Georg Northoff; Katharina M Kubera; Robert Christian Wolf Journal: Nervenarzt Date: 2021-06-11 Impact factor: 1.214
Authors: Olav B Smeland; Alexey Shadrin; Shahram Bahrami; Iris Broce; Martin Tesli; Oleksandr Frei; Katrine V Wirgenes; Kevin S O'Connell; Florian Krull; Francesco Bettella; Nils Eiel Steen; Leo Sugrue; Yunpeng Wang; Per Svenningsson; Manu Sharma; Lasse Pihlstrøm; Mathias Toft; Michael O'Donovan; Srdjan Djurovic; Rahul Desikan; Anders M Dale; Ole A Andreassen Journal: Biol Psychiatry Date: 2020-02-08 Impact factor: 13.382